Aromatic amino acids in weight-recovered females with anorexia nervosa

International Journal of Eating Disorders

Volumn 42, Issue 2, 2009, Pages 166-172

  Ehrlich, Stefan ^a   Franke, Leonora ^a   Schneider, Nora ^a   Salbach Andrae, Harriet ^a   Schott, Regina ^a   Craciun, Eugenia M ^a   Pfeiffer, Ernst ^a   Uebelhack, Ralf ^a   Lehmkuhl, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anorexia nervosa; Aromatic amino acids; Leptin; Tryptophan; Weight recovery

Indexed keywords

AROMATIC AMINO ACID; CATECHOLAMINE; LEPTIN; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; ANOREXIA NERVOSA; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; BRAIN; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DISEASE SEVERITY; EATING DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALNUTRITION; MULTIVARIATE ANALYSIS OF VARIANCE; NEUROTRANSMISSION; NUTRITIONAL STATUS; OUTPATIENT; PLASMA; PRIORITY JOURNAL; SCORING SYSTEM; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; STRUCTURED INTERVIEW; TREATMENT OUTCOME; UNDERWEIGHT; WEIGHT GAIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANOREXIA NERVOSA; CHILD; CONVALESCENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; PHENYLALANINE; TRYPTOPHAN; WEIGHT GAIN; YOUNG ADULT;

EID: 62649096757     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.20575     Document Type: Article

References (51)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
2. Brewerton TD. Toward a unified theory of serotonin dysregula-tion in eating and related disorders. Psychoneuroendocrinology 1995; 20: 561-590.
3. Lehnert H, Wurtman RJ. Amino acid control of neurotransmitter synthesis and release: Physiological and clinical implications. Psychother Psychosom 1993; 60: 18-32.
4. Nelson DL, Gehlert DR. Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 2006; 29: 49-60.
5. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human L-type amino acid transporter 1 (LAT1): Characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001; 1514: 291-302.
6. Wurtman RJ, Hefti F, Melamed E. Precursor control of neuro-transmitter synthesis. Pharmacol Rev 1980; 32: 315-335.
7. Askenazy F, Candito M, Caci H, Myquel M, Chambon P, Darcourt G, et al. Whole blood serotonin content, tryptophan concentrations, and impulsivity in anorexia nervosa. Biol Psychiatry 1998; 43: 188-195.
8. Attia E, Wolk S, Cooper T, Glasofer D, Walsh BT. Plasma trypto-phan during weight restoration in patients with anorexia nervosa. Biol Psychiatry 2005; 57: 674-678.
9. Demitrack MA, Heyes MP, Altemus M, Pigott TA, Gold PW. Cere-brospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: Relation to clinical and biochemical variable. Biol Psychiatry 1995; 37: 512-520.
10. Gerner RH, Cohen DJ, Fairbanks L, Anderson GM, Young JG, Scheinin M, et al. CSF neurochemistry of women with anorexia nervosa and normal women. Am J Psychiatry 1984; 141: 1441- 1444.
11. Goodwin GM, Shapiro CM, Bennie J, Dick H, Carroll S, Fink G. The neuroendocrine responses and psychological effects of infusion of L-tryptophan in anorexia nervosa. Psychol Med 1989; 19: 857-864.
12. Schreiber W, Schweiger U, Werner D, Brunner G, Tuschl RJ, Laessle RG, et al. Circadian pattern of large neutral amino acids, glucose, insulin, and food intake in anorexia nervosa and bulimia nervosa. Metabolism 1991; 40: 503-507.
13. Kaye WH, Ebert MH, Raleigh M, Lake R. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984; 41: 350-355.
14. Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res 1996; 62: 31-42.
15. Bruce KR, Steiger H, Ng Ying Kin NM, Israel M. Reduced platelet [3H]paroxetine binding in anorexia nervosa: Relationship to eating symptoms and personality pathology. Psychiatry Res 2006; 142: 225-232.
16. Fernstrom JD, Fernstrom MH. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr 2007; 137(6, Suppl 1): 1539S-1547S; discussion 1548S.
17. Gibson CJ, Wurtman RJ. Physiological control of brain catechol synthesis by brain tyrosine concentration. Biochem Pharmacol 1977; 26: 1137-1142.
18. Pirke KM. Central and peripheral noradrenalin regulation in eating disorders. Psychiatry Res 1996; 62: 43-49.
19. Kaye WH, George DT, Gwirtsman HE, Jimerson DC, Goldstein DS, Ebert MH, et al. Isoproterenol infusion test in anorexia nervosa: Assessment of pre- and post-beta-noradrenergic receptor activity. Psychopharmacol Bull 1990; 26: 355-359.
20. Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, et al. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [(11)C]raclopride. Biol Psychiatry 2005; 58: 908-912.
21. Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR. The significance and mechanism of an increased serum phenylala-nine-tyrosine ratio during infection. Am J Clin Nutr 1976; 29: 997-1006.
22. Zhang F, Chen Y, Heiman M, Dimarchi R. Leptin: Structure, function and biology. Vitam Horm 2005; 71: 345-372.
23. Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B. The role of leptin in anorexia nervosa: Clinical implications. Mol Psychiatry 2007; 12: 23-35.
24. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller D, Geiss HC, Hesse V, et al. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818.
25. Fichter M, Quadflieg N. SIAB. Strukturiertes Inventar für Anorektische und Bulimische Essstörungen nach DSM-IV und ICD-10. Bern: Huber, 1999.
26. Fichter M, Quadflieg N. The structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10 (SIAB-EX): Reliability and validity. Eur Psychiatry 2001; 16: 38-48.
27. Rathner G, Waldherr K. Eating disorder inventory-2. Eine deutschsprachige Validierung mit Normen für weibliche und männliche Jugendliche. Z Klin Psychol Psychiatr Psychother 1997; 45: 157-182.
28. Franke GH. SCL-90-R. Symptom-Checkliste von L.R. Derogatis-Deutsche Version. Göttingen: Beltz Test GMBH, 2002.
29. Wei J, Xu HM, Hemmings GP. Studies on neurochemical heterogeneity in healthy parents of schizophrenic patients. Schizophr Res 1993; 10: 173-178.
30. Hassanyeh F, Marshall EF. Measures of serotonin metabolism in anorexia nervosa. Acta Psychiatr Scand 1991; 84: 561-563.
31. Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, et al. Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. Int J Eat Disord 2003; 33: 257-267; discussion 268-270.
32. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 1990; 20: 785- 791.
33. Walsh AE, Oldman AD, Franklin M, Fairburn CG, Cowen PJ. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men. J Affect Disord 1995; 33: 89-97.
34. Moyano D, Vilaseca MA, Artuch R, Lambruschini N. Plasma amino acids in anorexia nervosa. Eur J Clin Nutr 1998; 52: 684- 689.
35. Halmi KA, Struss AL, Owen WP, Stegink LD. Plasma and erythrocyte amino acid concentrations in anorexia nervosa. JPEN J Parenter Enteral Nutr 1987; 11: 458-464.
36. Uhe AM, Szmukler GI, Collier GR, Hansky J, O'Dea K, Young GP. Potential regulators of feeding behavior in anorexia nervosa. Am J Clin Nutr 1992; 55: 28-32.
37. Palova S, Charvat J, Masopust J, Klapkova E, Kvapil M. Changes in the plasma amino acid profile in anorexia nervosa. J Int Med Res 2007; 35: 389-394.
38. Schweiger U, Warnhoff M, Pahl J, Pirke KM. Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose, and insulin plasma levels of anorectic patients. Metabolism 1986; 35: 938-943.
39. Coppen AJ, Gupta RK, Eccleston EG, Wood KM, Wakeling A, de Sousa VF. Letter: Plasma-tryptophan in anorexia nervosa. Lancet 1976; 1: 961.
40. Bastiani AM, Rao R, Weltzin T, Kaye WH. Perfectionism in anorexia nervosa. Int J Eat Disord 1995; 17: 147-152.
41. Jordan J, Joyce PR, Carter FA, Horn J, McIntosh VV, Luty SE, et al. Specific and nonspecific comorbidity in anorexia nervosa. Int J Eat Disord 2008; 41: 47-56.
42. Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 1998; 155: 548-551.
43. Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC, et al. Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. JAMA 2006; 295: 2605-2612.
44. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis CA, et al. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 2007; 61: 1090-1099.
45. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, et al. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 2005; 62: 1032-1041.
46. Kaye WH, Gwirtsman HE, George DT, Ebert MH. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 1991; 48: 556-562.
47. Wagner A, Aizenstein H, Venkatraman VK, Fudge J, May JC, Mazur-kewicz L, et al. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 2007; 164: 1842-1849.
48. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 2007; 30: 375-381.
49. Bosanac P, Norman T, Burrows G, Beumont P. Serotonergic and dopaminergic systems in anorexia nervosa: A role for atypical antipsychotics? Aust N Z J Psychiatry 2005; 39: 146-153.
50. Couturier JL, Lock J. Denial and minimization in adolescents with anorexia nervosa. Int J Eat Disord 2006; 39: 212-216.
51. Balasse EO. Kinetics of ketone body metabolism in fasting humans. Metabolism 1979; 28: 41-50.